Adverse drug reactions in Canada.
D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced; D000890:Anti-Infective Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D002110:Caffeine / Q000009:adverse effects; D002170:Canada; D002443:Ceftriaxone / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002648:Child; D004347:Drug Interactions; D005260:Female; D006801:Humans; D048628:Ketolides / Q000009:adverse effects; D008875:Middle Aged; D000077152:Olanzapine; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D008517:Phytotherapy / Q000009:adverse effects; D011655:Pulmonary Embolism / Q000139:chemically induced; D012206:Rhabdomyolysis / Q000139:chemically induced; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D014859:Warfarin / Q000009:adverse effects; D015431:Weight Loss
D000890:Anti-Infective Agents; D000925:Anticoagulants; D001569:Benzodiazepines; D002110:Caffeine; D002443:Ceftriaxone; D000697:Central Nervous System Stimulants; D048628:Ketolides; D000077152:Olanzapine; D017367:Selective Serotonin Reuptake Inhibitors; D014859:Warfarin; C106791:telithromycin